nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosamprenavir—CYP3A4—Everolimus—kidney cancer	0.193	0.293	CbGbCtD
Fosamprenavir—CYP3A4—Temsirolimus—kidney cancer	0.13	0.198	CbGbCtD
Fosamprenavir—CYP3A4—Pazopanib—kidney cancer	0.0685	0.104	CbGbCtD
Fosamprenavir—CYP3A4—Erlotinib—kidney cancer	0.0489	0.0741	CbGbCtD
Fosamprenavir—CYP3A4—Paclitaxel—kidney cancer	0.0447	0.0678	CbGbCtD
Fosamprenavir—CYP3A4—Sorafenib—kidney cancer	0.0397	0.0603	CbGbCtD
Fosamprenavir—CYP3A4—Vinblastine—kidney cancer	0.0392	0.0595	CbGbCtD
Fosamprenavir—CYP3A4—Vincristine—kidney cancer	0.0386	0.0585	CbGbCtD
Fosamprenavir—CYP3A4—Sunitinib—kidney cancer	0.0322	0.0488	CbGbCtD
Fosamprenavir—CYP3A4—Doxorubicin—kidney cancer	0.0241	0.0366	CbGbCtD
Fosamprenavir—Amprenavir—ABCB1—kidney cancer	0.000642	1	CrCbGaD
Fosamprenavir—Nervous system disorder—Sorafenib—kidney cancer	0.000537	0.00158	CcSEcCtD
Fosamprenavir—Rash—Temsirolimus—kidney cancer	0.000535	0.00157	CcSEcCtD
Fosamprenavir—Dermatitis—Temsirolimus—kidney cancer	0.000534	0.00157	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Capecitabine—kidney cancer	0.000532	0.00157	CcSEcCtD
Fosamprenavir—Skin disorder—Sorafenib—kidney cancer	0.000532	0.00156	CcSEcCtD
Fosamprenavir—Headache—Temsirolimus—kidney cancer	0.000531	0.00156	CcSEcCtD
Fosamprenavir—Decreased appetite—Erlotinib—kidney cancer	0.000529	0.00156	CcSEcCtD
Fosamprenavir—Dizziness—Pazopanib—kidney cancer	0.000528	0.00155	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000525	0.00155	CcSEcCtD
Fosamprenavir—Fatigue—Erlotinib—kidney cancer	0.000525	0.00154	CcSEcCtD
Fosamprenavir—Gastritis—Capecitabine—kidney cancer	0.000523	0.00154	CcSEcCtD
Fosamprenavir—Anorexia—Sorafenib—kidney cancer	0.000522	0.00154	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Capecitabine—kidney cancer	0.000521	0.00153	CcSEcCtD
Fosamprenavir—Myalgia—Dactinomycin—kidney cancer	0.00052	0.00153	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Vinblastine—kidney cancer	0.000518	0.00152	CcSEcCtD
Fosamprenavir—Nervous system disorder—Sunitinib—kidney cancer	0.000517	0.00152	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Everolimus—kidney cancer	0.000516	0.00152	CcSEcCtD
Fosamprenavir—Skin disorder—Sunitinib—kidney cancer	0.000512	0.00151	CcSEcCtD
Fosamprenavir—Vomiting—Pazopanib—kidney cancer	0.000508	0.00149	CcSEcCtD
Fosamprenavir—Rash—Pazopanib—kidney cancer	0.000504	0.00148	CcSEcCtD
Fosamprenavir—Nausea—Temsirolimus—kidney cancer	0.000504	0.00148	CcSEcCtD
Fosamprenavir—Dermatitis—Pazopanib—kidney cancer	0.000503	0.00148	CcSEcCtD
Fosamprenavir—Anorexia—Sunitinib—kidney cancer	0.000502	0.00148	CcSEcCtD
Fosamprenavir—Haemoglobin—Paclitaxel—kidney cancer	0.000501	0.00147	CcSEcCtD
Fosamprenavir—Abdominal pain—Vinblastine—kidney cancer	0.000501	0.00147	CcSEcCtD
Fosamprenavir—Headache—Pazopanib—kidney cancer	0.0005	0.00147	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000499	0.00147	CcSEcCtD
Fosamprenavir—Abdominal pain—Everolimus—kidney cancer	0.000499	0.00147	CcSEcCtD
Fosamprenavir—Body temperature increased—Everolimus—kidney cancer	0.000499	0.00147	CcSEcCtD
Fosamprenavir—Haemorrhage—Paclitaxel—kidney cancer	0.000498	0.00147	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Erlotinib—kidney cancer	0.000498	0.00146	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Paclitaxel—kidney cancer	0.000492	0.00145	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Paclitaxel—kidney cancer	0.00049	0.00144	CcSEcCtD
Fosamprenavir—Urethral disorder—Paclitaxel—kidney cancer	0.000488	0.00144	CcSEcCtD
Fosamprenavir—Abdominal pain—Erlotinib—kidney cancer	0.000481	0.00142	CcSEcCtD
Fosamprenavir—Body temperature increased—Erlotinib—kidney cancer	0.000481	0.00142	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.00048	0.00141	CcSEcCtD
Fosamprenavir—Neutropenia—Capecitabine—kidney cancer	0.000478	0.0014	CcSEcCtD
Fosamprenavir—Decreased appetite—Sorafenib—kidney cancer	0.000476	0.0014	CcSEcCtD
Fosamprenavir—Anorexia—Dactinomycin—kidney cancer	0.000475	0.0014	CcSEcCtD
Fosamprenavir—Nausea—Pazopanib—kidney cancer	0.000475	0.0014	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000473	0.00139	CcSEcCtD
Fosamprenavir—Fatigue—Sorafenib—kidney cancer	0.000472	0.00139	CcSEcCtD
Fosamprenavir—Erythema multiforme—Paclitaxel—kidney cancer	0.000471	0.00139	CcSEcCtD
Fosamprenavir—Hypersensitivity—Vinblastine—kidney cancer	0.000467	0.00137	CcSEcCtD
Fosamprenavir—Myalgia—Vincristine—kidney cancer	0.000465	0.00137	CcSEcCtD
Fosamprenavir—Hypersensitivity—Everolimus—kidney cancer	0.000465	0.00137	CcSEcCtD
Fosamprenavir—Cardiac disorder—Paclitaxel—kidney cancer	0.000462	0.00136	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Capecitabine—kidney cancer	0.000461	0.00136	CcSEcCtD
Fosamprenavir—Decreased appetite—Sunitinib—kidney cancer	0.000458	0.00135	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000455	0.00134	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000454	0.00134	CcSEcCtD
Fosamprenavir—Asthenia—Vinblastine—kidney cancer	0.000454	0.00134	CcSEcCtD
Fosamprenavir—Fatigue—Sunitinib—kidney cancer	0.000454	0.00134	CcSEcCtD
Fosamprenavir—Asthenia—Everolimus—kidney cancer	0.000453	0.00133	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000452	0.00133	CcSEcCtD
Fosamprenavir—Immune system disorder—Paclitaxel—kidney cancer	0.00045	0.00132	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Capecitabine—kidney cancer	0.000449	0.00132	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Sorafenib—kidney cancer	0.000448	0.00132	CcSEcCtD
Fosamprenavir—Myocardial infarction—Capecitabine—kidney cancer	0.000446	0.00131	CcSEcCtD
Fosamprenavir—Pruritus—Everolimus—kidney cancer	0.000446	0.00131	CcSEcCtD
Fosamprenavir—Myalgia—Gemcitabine—kidney cancer	0.000441	0.0013	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Doxorubicin—kidney cancer	0.000438	0.00129	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000438	0.00129	CcSEcCtD
Fosamprenavir—Nervous system disorder—Vincristine—kidney cancer	0.000437	0.00129	CcSEcCtD
Fosamprenavir—Asthenia—Erlotinib—kidney cancer	0.000437	0.00128	CcSEcCtD
Fosamprenavir—Malnutrition—Paclitaxel—kidney cancer	0.000434	0.00128	CcSEcCtD
Fosamprenavir—Decreased appetite—Dactinomycin—kidney cancer	0.000434	0.00128	CcSEcCtD
Fosamprenavir—Diarrhoea—Vinblastine—kidney cancer	0.000433	0.00127	CcSEcCtD
Fosamprenavir—Body temperature increased—Sorafenib—kidney cancer	0.000433	0.00127	CcSEcCtD
Fosamprenavir—Abdominal pain—Sorafenib—kidney cancer	0.000433	0.00127	CcSEcCtD
Fosamprenavir—Diarrhoea—Everolimus—kidney cancer	0.000432	0.00127	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Sunitinib—kidney cancer	0.000431	0.00127	CcSEcCtD
Fosamprenavir—Pruritus—Erlotinib—kidney cancer	0.000431	0.00127	CcSEcCtD
Fosamprenavir—Fatigue—Dactinomycin—kidney cancer	0.00043	0.00126	CcSEcCtD
Fosamprenavir—Flatulence—Paclitaxel—kidney cancer	0.000427	0.00126	CcSEcCtD
Fosamprenavir—Anorexia—Vincristine—kidney cancer	0.000425	0.00125	CcSEcCtD
Fosamprenavir—Dizziness—Vinblastine—kidney cancer	0.000419	0.00123	CcSEcCtD
Fosamprenavir—Dizziness—Everolimus—kidney cancer	0.000417	0.00123	CcSEcCtD
Fosamprenavir—Body temperature increased—Sunitinib—kidney cancer	0.000416	0.00123	CcSEcCtD
Fosamprenavir—Abdominal pain—Sunitinib—kidney cancer	0.000416	0.00123	CcSEcCtD
Fosamprenavir—Diarrhoea—Erlotinib—kidney cancer	0.000416	0.00122	CcSEcCtD
Fosamprenavir—Nervous system disorder—Gemcitabine—kidney cancer	0.000415	0.00122	CcSEcCtD
Fosamprenavir—Haemoglobin—Capecitabine—kidney cancer	0.000411	0.00121	CcSEcCtD
Fosamprenavir—Skin disorder—Gemcitabine—kidney cancer	0.000411	0.00121	CcSEcCtD
Fosamprenavir—Haemorrhage—Capecitabine—kidney cancer	0.000409	0.0012	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000408	0.0012	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000406	0.00119	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Capecitabine—kidney cancer	0.000404	0.00119	CcSEcCtD
Fosamprenavir—Hypersensitivity—Sorafenib—kidney cancer	0.000403	0.00119	CcSEcCtD
Fosamprenavir—Anorexia—Gemcitabine—kidney cancer	0.000403	0.00119	CcSEcCtD
Fosamprenavir—Vomiting—Vinblastine—kidney cancer	0.000403	0.00118	CcSEcCtD
Fosamprenavir—Dizziness—Erlotinib—kidney cancer	0.000402	0.00118	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Capecitabine—kidney cancer	0.000402	0.00118	CcSEcCtD
Fosamprenavir—Vomiting—Everolimus—kidney cancer	0.000401	0.00118	CcSEcCtD
Fosamprenavir—Urethral disorder—Capecitabine—kidney cancer	0.000401	0.00118	CcSEcCtD
Fosamprenavir—Rash—Everolimus—kidney cancer	0.000398	0.00117	CcSEcCtD
Fosamprenavir—Dermatitis—Everolimus—kidney cancer	0.000397	0.00117	CcSEcCtD
Fosamprenavir—Headache—Vinblastine—kidney cancer	0.000397	0.00117	CcSEcCtD
Fosamprenavir—Angioedema—Paclitaxel—kidney cancer	0.000396	0.00117	CcSEcCtD
Fosamprenavir—Headache—Everolimus—kidney cancer	0.000395	0.00116	CcSEcCtD
Fosamprenavir—Abdominal pain—Dactinomycin—kidney cancer	0.000394	0.00116	CcSEcCtD
Fosamprenavir—Body temperature increased—Dactinomycin—kidney cancer	0.000394	0.00116	CcSEcCtD
Fosamprenavir—Asthenia—Sorafenib—kidney cancer	0.000393	0.00116	CcSEcCtD
Fosamprenavir—Hypersensitivity—Sunitinib—kidney cancer	0.000388	0.00114	CcSEcCtD
Fosamprenavir—Decreased appetite—Vincristine—kidney cancer	0.000387	0.00114	CcSEcCtD
Fosamprenavir—Pruritus—Sorafenib—kidney cancer	0.000387	0.00114	CcSEcCtD
Fosamprenavir—Vomiting—Erlotinib—kidney cancer	0.000387	0.00114	CcSEcCtD
Fosamprenavir—Erythema multiforme—Capecitabine—kidney cancer	0.000387	0.00114	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000385	0.00113	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Vincristine—kidney cancer	0.000385	0.00113	CcSEcCtD
Fosamprenavir—Fatigue—Vincristine—kidney cancer	0.000384	0.00113	CcSEcCtD
Fosamprenavir—Rash—Erlotinib—kidney cancer	0.000384	0.00113	CcSEcCtD
Fosamprenavir—Dermatitis—Erlotinib—kidney cancer	0.000383	0.00113	CcSEcCtD
Fosamprenavir—Headache—Erlotinib—kidney cancer	0.000381	0.00112	CcSEcCtD
Fosamprenavir—Cardiac disorder—Capecitabine—kidney cancer	0.000379	0.00112	CcSEcCtD
Fosamprenavir—Asthenia—Sunitinib—kidney cancer	0.000378	0.00111	CcSEcCtD
Fosamprenavir—Nausea—Vinblastine—kidney cancer	0.000376	0.00111	CcSEcCtD
Fosamprenavir—Nausea—Everolimus—kidney cancer	0.000375	0.0011	CcSEcCtD
Fosamprenavir—Diarrhoea—Sorafenib—kidney cancer	0.000375	0.0011	CcSEcCtD
Fosamprenavir—Pruritus—Sunitinib—kidney cancer	0.000373	0.0011	CcSEcCtD
Fosamprenavir—Immune system disorder—Capecitabine—kidney cancer	0.000369	0.00109	CcSEcCtD
Fosamprenavir—Myalgia—Paclitaxel—kidney cancer	0.000369	0.00109	CcSEcCtD
Fosamprenavir—Decreased appetite—Gemcitabine—kidney cancer	0.000367	0.00108	CcSEcCtD
Fosamprenavir—Hypersensitivity—Dactinomycin—kidney cancer	0.000367	0.00108	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000367	0.00108	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000365	0.00107	CcSEcCtD
Fosamprenavir—Fatigue—Gemcitabine—kidney cancer	0.000364	0.00107	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Vincristine—kidney cancer	0.000364	0.00107	CcSEcCtD
Fosamprenavir—Dizziness—Sorafenib—kidney cancer	0.000362	0.00107	CcSEcCtD
Fosamprenavir—Nausea—Erlotinib—kidney cancer	0.000362	0.00106	CcSEcCtD
Fosamprenavir—Diarrhoea—Sunitinib—kidney cancer	0.00036	0.00106	CcSEcCtD
Fosamprenavir—Asthenia—Dactinomycin—kidney cancer	0.000358	0.00105	CcSEcCtD
Fosamprenavir—Malnutrition—Capecitabine—kidney cancer	0.000356	0.00105	CcSEcCtD
Fosamprenavir—Abdominal pain—Vincristine—kidney cancer	0.000352	0.00104	CcSEcCtD
Fosamprenavir—Body temperature increased—Vincristine—kidney cancer	0.000352	0.00104	CcSEcCtD
Fosamprenavir—Flatulence—Capecitabine—kidney cancer	0.000351	0.00103	CcSEcCtD
Fosamprenavir—Dizziness—Sunitinib—kidney cancer	0.000348	0.00102	CcSEcCtD
Fosamprenavir—Vomiting—Sorafenib—kidney cancer	0.000348	0.00102	CcSEcCtD
Fosamprenavir—Nervous system disorder—Paclitaxel—kidney cancer	0.000347	0.00102	CcSEcCtD
Fosamprenavir—Rash—Sorafenib—kidney cancer	0.000345	0.00102	CcSEcCtD
Fosamprenavir—Dermatitis—Sorafenib—kidney cancer	0.000345	0.00101	CcSEcCtD
Fosamprenavir—Skin disorder—Paclitaxel—kidney cancer	0.000344	0.00101	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000343	0.00101	CcSEcCtD
Fosamprenavir—Headache—Sorafenib—kidney cancer	0.000343	0.00101	CcSEcCtD
Fosamprenavir—Diarrhoea—Dactinomycin—kidney cancer	0.000341	0.001	CcSEcCtD
Fosamprenavir—Anorexia—Paclitaxel—kidney cancer	0.000337	0.000992	CcSEcCtD
Fosamprenavir—Gastritis—Doxorubicin—kidney cancer	0.000337	0.000992	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000336	0.000988	CcSEcCtD
Fosamprenavir—Vomiting—Sunitinib—kidney cancer	0.000335	0.000985	CcSEcCtD
Fosamprenavir—Body temperature increased—Gemcitabine—kidney cancer	0.000334	0.000983	CcSEcCtD
Fosamprenavir—Rash—Sunitinib—kidney cancer	0.000332	0.000977	CcSEcCtD
Fosamprenavir—Dermatitis—Sunitinib—kidney cancer	0.000332	0.000976	CcSEcCtD
Fosamprenavir—Headache—Sunitinib—kidney cancer	0.00033	0.000971	CcSEcCtD
Fosamprenavir—Hypersensitivity—Vincristine—kidney cancer	0.000328	0.000966	CcSEcCtD
Fosamprenavir—Nausea—Sorafenib—kidney cancer	0.000325	0.000957	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000322	0.000949	CcSEcCtD
Fosamprenavir—Asthenia—Vincristine—kidney cancer	0.00032	0.00094	CcSEcCtD
Fosamprenavir—Vomiting—Dactinomycin—kidney cancer	0.000317	0.000933	CcSEcCtD
Fosamprenavir—Rash—Dactinomycin—kidney cancer	0.000314	0.000925	CcSEcCtD
Fosamprenavir—Nausea—Sunitinib—kidney cancer	0.000313	0.000921	CcSEcCtD
Fosamprenavir—Neutropenia—Doxorubicin—kidney cancer	0.000308	0.000906	CcSEcCtD
Fosamprenavir—Decreased appetite—Paclitaxel—kidney cancer	0.000308	0.000905	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000306	0.000899	CcSEcCtD
Fosamprenavir—Fatigue—Paclitaxel—kidney cancer	0.000305	0.000898	CcSEcCtD
Fosamprenavir—Diarrhoea—Vincristine—kidney cancer	0.000305	0.000897	CcSEcCtD
Fosamprenavir—Asthenia—Gemcitabine—kidney cancer	0.000303	0.000892	CcSEcCtD
Fosamprenavir—Myalgia—Capecitabine—kidney cancer	0.000303	0.000891	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000301	0.000885	CcSEcCtD
Fosamprenavir—Pruritus—Gemcitabine—kidney cancer	0.000299	0.00088	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Doxorubicin—kidney cancer	0.000297	0.000874	CcSEcCtD
Fosamprenavir—Nausea—Dactinomycin—kidney cancer	0.000296	0.000871	CcSEcCtD
Fosamprenavir—Dizziness—Vincristine—kidney cancer	0.000295	0.000867	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000291	0.000856	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000289	0.000851	CcSEcCtD
Fosamprenavir—Diarrhoea—Gemcitabine—kidney cancer	0.000289	0.000851	CcSEcCtD
Fosamprenavir—Nervous system disorder—Capecitabine—kidney cancer	0.000285	0.000838	CcSEcCtD
Fosamprenavir—Vomiting—Vincristine—kidney cancer	0.000283	0.000833	CcSEcCtD
Fosamprenavir—Skin disorder—Capecitabine—kidney cancer	0.000282	0.00083	CcSEcCtD
Fosamprenavir—Rash—Vincristine—kidney cancer	0.000281	0.000826	CcSEcCtD
Fosamprenavir—Dermatitis—Vincristine—kidney cancer	0.000281	0.000826	CcSEcCtD
Fosamprenavir—Body temperature increased—Paclitaxel—kidney cancer	0.00028	0.000823	CcSEcCtD
Fosamprenavir—Abdominal pain—Paclitaxel—kidney cancer	0.00028	0.000823	CcSEcCtD
Fosamprenavir—Headache—Vincristine—kidney cancer	0.000279	0.000821	CcSEcCtD
Fosamprenavir—Anorexia—Capecitabine—kidney cancer	0.000277	0.000814	CcSEcCtD
Fosamprenavir—Vomiting—Gemcitabine—kidney cancer	0.000269	0.000791	CcSEcCtD
Fosamprenavir—Rash—Gemcitabine—kidney cancer	0.000267	0.000784	CcSEcCtD
Fosamprenavir—Dermatitis—Gemcitabine—kidney cancer	0.000266	0.000783	CcSEcCtD
Fosamprenavir—Haemoglobin—Doxorubicin—kidney cancer	0.000265	0.000779	CcSEcCtD
Fosamprenavir—Headache—Gemcitabine—kidney cancer	0.000265	0.000779	CcSEcCtD
Fosamprenavir—Nausea—Vincristine—kidney cancer	0.000265	0.000779	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000265	0.000778	CcSEcCtD
Fosamprenavir—Haemorrhage—Doxorubicin—kidney cancer	0.000264	0.000775	CcSEcCtD
Fosamprenavir—Hypersensitivity—Paclitaxel—kidney cancer	0.000261	0.000767	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Doxorubicin—kidney cancer	0.00026	0.000766	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Doxorubicin—kidney cancer	0.000259	0.000762	CcSEcCtD
Fosamprenavir—Urethral disorder—Doxorubicin—kidney cancer	0.000258	0.00076	CcSEcCtD
Fosamprenavir—Asthenia—Paclitaxel—kidney cancer	0.000254	0.000747	CcSEcCtD
Fosamprenavir—Decreased appetite—Capecitabine—kidney cancer	0.000252	0.000743	CcSEcCtD
Fosamprenavir—Nausea—Gemcitabine—kidney cancer	0.000251	0.000739	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000251	0.000738	CcSEcCtD
Fosamprenavir—Fatigue—Capecitabine—kidney cancer	0.00025	0.000737	CcSEcCtD
Fosamprenavir—Pruritus—Paclitaxel—kidney cancer	0.00025	0.000737	CcSEcCtD
Fosamprenavir—Erythema multiforme—Doxorubicin—kidney cancer	0.000249	0.000733	CcSEcCtD
Fosamprenavir—Cardiac disorder—Doxorubicin—kidney cancer	0.000245	0.000719	CcSEcCtD
Fosamprenavir—Diarrhoea—Paclitaxel—kidney cancer	0.000242	0.000712	CcSEcCtD
Fosamprenavir—Immune system disorder—Doxorubicin—kidney cancer	0.000238	0.0007	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Capecitabine—kidney cancer	0.000238	0.000699	CcSEcCtD
Fosamprenavir—Dizziness—Paclitaxel—kidney cancer	0.000234	0.000688	CcSEcCtD
Fosamprenavir—Body temperature increased—Capecitabine—kidney cancer	0.00023	0.000675	CcSEcCtD
Fosamprenavir—Abdominal pain—Capecitabine—kidney cancer	0.00023	0.000675	CcSEcCtD
Fosamprenavir—Malnutrition—Doxorubicin—kidney cancer	0.000229	0.000675	CcSEcCtD
Fosamprenavir—Flatulence—Doxorubicin—kidney cancer	0.000226	0.000665	CcSEcCtD
Fosamprenavir—Vomiting—Paclitaxel—kidney cancer	0.000225	0.000662	CcSEcCtD
Fosamprenavir—Rash—Paclitaxel—kidney cancer	0.000223	0.000656	CcSEcCtD
Fosamprenavir—Dermatitis—Paclitaxel—kidney cancer	0.000223	0.000656	CcSEcCtD
Fosamprenavir—Headache—Paclitaxel—kidney cancer	0.000222	0.000652	CcSEcCtD
Fosamprenavir—Hypersensitivity—Capecitabine—kidney cancer	0.000214	0.000629	CcSEcCtD
Fosamprenavir—Nausea—Paclitaxel—kidney cancer	0.00021	0.000618	CcSEcCtD
Fosamprenavir—Asthenia—Capecitabine—kidney cancer	0.000208	0.000613	CcSEcCtD
Fosamprenavir—Pruritus—Capecitabine—kidney cancer	0.000205	0.000604	CcSEcCtD
Fosamprenavir—Diarrhoea—Capecitabine—kidney cancer	0.000199	0.000585	CcSEcCtD
Fosamprenavir—Myalgia—Doxorubicin—kidney cancer	0.000195	0.000575	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000194	0.000571	CcSEcCtD
Fosamprenavir—Dizziness—Capecitabine—kidney cancer	0.000192	0.000565	CcSEcCtD
Fosamprenavir—Vomiting—Capecitabine—kidney cancer	0.000185	0.000543	CcSEcCtD
Fosamprenavir—Nervous system disorder—Doxorubicin—kidney cancer	0.000184	0.00054	CcSEcCtD
Fosamprenavir—Rash—Capecitabine—kidney cancer	0.000183	0.000539	CcSEcCtD
Fosamprenavir—Dermatitis—Capecitabine—kidney cancer	0.000183	0.000538	CcSEcCtD
Fosamprenavir—Headache—Capecitabine—kidney cancer	0.000182	0.000535	CcSEcCtD
Fosamprenavir—Skin disorder—Doxorubicin—kidney cancer	0.000182	0.000535	CcSEcCtD
Fosamprenavir—Anorexia—Doxorubicin—kidney cancer	0.000178	0.000525	CcSEcCtD
Fosamprenavir—Nausea—Capecitabine—kidney cancer	0.000173	0.000508	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000171	0.000502	CcSEcCtD
Fosamprenavir—Decreased appetite—Doxorubicin—kidney cancer	0.000163	0.000479	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000162	0.000475	CcSEcCtD
Fosamprenavir—Fatigue—Doxorubicin—kidney cancer	0.000161	0.000475	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000153	0.00045	CcSEcCtD
Fosamprenavir—Abdominal pain—Doxorubicin—kidney cancer	0.000148	0.000435	CcSEcCtD
Fosamprenavir—Body temperature increased—Doxorubicin—kidney cancer	0.000148	0.000435	CcSEcCtD
Fosamprenavir—Hypersensitivity—Doxorubicin—kidney cancer	0.000138	0.000406	CcSEcCtD
Fosamprenavir—Asthenia—Doxorubicin—kidney cancer	0.000134	0.000395	CcSEcCtD
Fosamprenavir—Pruritus—Doxorubicin—kidney cancer	0.000132	0.00039	CcSEcCtD
Fosamprenavir—Diarrhoea—Doxorubicin—kidney cancer	0.000128	0.000377	CcSEcCtD
Fosamprenavir—Dizziness—Doxorubicin—kidney cancer	0.000124	0.000364	CcSEcCtD
Fosamprenavir—Vomiting—Doxorubicin—kidney cancer	0.000119	0.00035	CcSEcCtD
Fosamprenavir—Rash—Doxorubicin—kidney cancer	0.000118	0.000347	CcSEcCtD
Fosamprenavir—Dermatitis—Doxorubicin—kidney cancer	0.000118	0.000347	CcSEcCtD
Fosamprenavir—Headache—Doxorubicin—kidney cancer	0.000117	0.000345	CcSEcCtD
Fosamprenavir—Nausea—Doxorubicin—kidney cancer	0.000111	0.000327	CcSEcCtD
